In both CMS and post-synaptic myasthenia gravis, I understand that the receptors of acetylcholine are impaired. Why then would an acetylcholinesterase inhibitor treats one problem and aggravates the other ?

More Pauline Schaffner's questions See All
Similar questions and discussions